Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) increases type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) with insulin resistance. We hypothesized that a 35 g whey preload would improve insulin sensitivity and glucose handling while reducing biomarkers associated with NAFLD. Twenty-nine age-matched w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zumbro, Emily L., Rao, Manisha, Balcom-Luker, Shenavia, Broughton, K. Shane, LeMieux, Monique J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308637/
https://www.ncbi.nlm.nih.gov/pubmed/34371959
http://dx.doi.org/10.3390/nu13072451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308637/
https://www.ncbi.nlm.nih.gov/pubmed/34371959
http://dx.doi.org/10.3390/nu13072451

Ejemplares similares